To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Biomarker-guided clusteri… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Biomarker-guided clustering of Alzheimer's disease clinical syndromes.

Journal article
Authors Nicola Toschi
Simone Lista
Filippo Baldacci
Enrica Cavedo
Henrik Zetterberg
Kaj Blennow
Ingo Kilimann
Stefan J Teipel
Antonio Melo Dos Santos
Stéphane Epelbaum
Foudil Lamari
Remy Genthon
Marie-Odile Habert
Bruno Dubois
Roberto Floris
Francesco Garaci
Andrea Vergallo
Harald Hampel
Published in Neurobiology of aging
Volume 83
Pages 42-53
ISSN 1558-1497
Publication year 2019
Published at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Pages 42-53
Language en
Subject categories Neurochemistry


Alzheimer's disease (AD) neuropathology is extremely heterogeneous, and the evolution from preclinical to mild cognitive impairment until dementia is driven by interacting genetic/biological mechanisms not fully captured by current clinical/research criteria. We characterized the heterogeneous "construct" of AD through a cerebrospinal fluid biomarker-guided stratification approach. We analyzed 5 validated pathophysiological cerebrospinal fluid biomarkers (Aβ1-42, t-tau, p-tau181, NFL, YKL-40) in 113 participants (healthy controls [N = 20], subjective memory complainers [N = 36], mild cognitive impairment [N = 20], and AD dementia [N = 37], age: 66.7 ± 10.4, 70.4 ± 7.7, 71.7 ± 8.4, 76.2 ± 3.5 years [mean ± SD], respectively) using Density-Based Spatial Clustering of Applications with Noise, which does not require a priori determination of the number of clusters. We found 5 distinct clusters (sizes: N = 38, 16, 24, 14, and 21) whose composition was independent of phenotypical groups. Two clusters showed biomarker profiles linked to neurodegenerative processes not associated with classical AD-related pathophysiology. One cluster was characterized by the neuroinflammation biomarker YKL-40. Combining nonlinear data aggregation with informative biomarkers can generate novel patient strata which are representative of cellular/molecular pathophysiology and may aid in predicting disease evolution and mechanistic drug response.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?